Needham & Company Remains Confident in Sarepta Therapeutic (SRPT) Approval

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/2/2026

1. PANW
2. GTLB
3. DELL
4. MDB
5. GOOGL
6. VRTS
7. SPY
8. HPE
9. USO
10. SNOW

Go back to Needham & Company Remains Confident in Sarepta Therapeutic (SRPT) Approval
SAREPTA THERAP (NASDAQ: SRPT) Delayed: 23.21 +1.88 (8.81%)
Previous Close $21.33    52 Week High $63.73 
Open $21.33    52 Week Low $8.00 
Day High $23.62    P/E N/A 
Day Low $21.33    EPS $-5.69 
Volume 4,806,621